tiprankstipranks
Advertisement
Advertisement

SE:VIVE Stock Latest News

Vivesto Advances Cantrixil With First Dogs Dosed in PK/Toxicology Study
Company AnnouncementsVivesto Advances Cantrixil With First Dogs Dosed in PK/Toxicology Study
14d ago
Vivesto Boosts Share Count After Rights and Set-Off Issues
PremiumCompany Announcements
Vivesto Boosts Share Count After Rights and Set-Off Issues
28d ago
Vivesto Settles Rights Issue Guarantee Fees with Directed Share Issue to Preserve Cash
PremiumCompany Announcements
Vivesto Settles Rights Issue Guarantee Fees with Directed Share Issue to Preserve Cash
2M ago
Vivesto Raises SEK 53.8 Million in Fully Subscribed Rights Issue With Significant Shareholder Dilution
PremiumCompany Announcements
Vivesto Raises SEK 53.8 Million in Fully Subscribed Rights Issue With Significant Shareholder Dilution
2M ago
Vivesto Launches Fully Covered SEK 53.8 Million Rights Issue to Fund Veterinary Oncology Pipeline
PremiumCompany Announcements
Vivesto Launches Fully Covered SEK 53.8 Million Rights Issue to Fund Veterinary Oncology Pipeline
3M ago
Vivesto Shareholders Approve Heavily Guaranteed Rights Issue to Bolster Cancer Drug Development
PremiumCompany AnnouncementsVivesto Shareholders Approve Heavily Guaranteed Rights Issue to Bolster Cancer Drug Development
3M ago
Vivesto Engages Liberi Group to Boost Partnering for Key Oncology Programs
Premium
Company Announcements
Vivesto Engages Liberi Group to Boost Partnering for Key Oncology Programs
3M ago
Vivesto AB Showcases Promising Oncology Developments in Business Update
Premium
Company Announcements
Vivesto AB Showcases Promising Oncology Developments in Business Update
4M ago
Vivesto AB Announces SEK 53.8 Million Rights Issue to Fund Key Projects
PremiumCompany Announcements
Vivesto AB Announces SEK 53.8 Million Rights Issue to Fund Key Projects
4M ago
Vivesto AB Announces Extraordinary General Meeting for Shareholder Resolutions
PremiumCompany Announcements
Vivesto AB Announces Extraordinary General Meeting for Shareholder Resolutions
4M ago
Vivesto AB to Present Key Oncology Developments in Upcoming Business Update
PremiumCompany Announcements
Vivesto AB to Present Key Oncology Developments in Upcoming Business Update
4M ago
Vivesto AB Reports Promising Interim Results for Paccal Vet in Canine Cancer Study
PremiumCompany Announcements
Vivesto AB Reports Promising Interim Results for Paccal Vet in Canine Cancer Study
5M ago
Vivesto AB Appoints Nomination Committee for 2026 AGM
PremiumCompany AnnouncementsVivesto AB Appoints Nomination Committee for 2026 AGM
5M ago
Vivesto Reports Positive Preclinical Results for Cantrixil in AML
Premium
Company Announcements
Vivesto Reports Positive Preclinical Results for Cantrixil in AML
5M ago
Vivesto AB Begins Paccal Vet Study in Cats
Premium
Company Announcements
Vivesto AB Begins Paccal Vet Study in Cats
7M ago
Vivesto AB’s AGM Approves Key Resolutions and Strategic Financial Flexibility
PremiumCompany AnnouncementsVivesto AB’s AGM Approves Key Resolutions and Strategic Financial Flexibility
11M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >